List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #20,911 to #20,960.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. F.W. AstonFrancis William Aston
  2. F. necrophorumFusobacterium necrophorum
  3. F2RCoagulation factor II receptor
  4. F508delΔF508
  5. F508del-CFTRΔF508
  6. FAFanconi anemia
  7. FAAHFatty acid amide hydrolase
  8. FAATFatty Acid Antiarrhythmia Trial
  9. FACITFolate After Coronary Intervention Trial
  10. FACSFellow of the American College of Surgeons
  11. FACSMFellow of the American College of Sports Medicine
  12. FACTEffect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
  13. FAC regimenCAF regimen
  14. FADHFlavin
  15. FAH geneFumarylacetoacetate hydrolase
  16. FALSAmyotrophic lateral sclerosis
  17. FAMISFosinopril In Acute Myocardial Infarction Study
  18. FANCC geneFanconi anemia, complementation group C
  19. FANCG geneFANCG
  20. FANTASTICRandomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
  21. FAOFood and Agriculture Organization
  22. FASTFemoral Artery Stenting Trial
  23. FAST-MAGField Administration Of Stroke Therapy - Magnesium
  24. FASTERFibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
  25. FAS ligandFas ligand
  26. FATSFamilial Atherosclerosis Treatment Study (FATS)
  27. FATS TrialFamilial Atherosclerosis Treatment Study (FATS)
  28. FATS trialFamilial Atherosclerosis Treatment Study (FATS)
  29. FAVAProvisionally unclassified vascular anomalies#Fibro adipose vascular anomaly (FAVA)
  30. FBGBlood sugar
  31. FBSBlood sugar
  32. FCM-R regimenFMC-R regimen
  33. FCMR RegimenFMC-R regimen
  34. FCM regimenFMC regimen
  35. FD&CFederal Food, Drug, and Cosmetic Act
  36. FDAFood and Drug Administration
  37. FDA Advisors Under Review for the Potential of Financial Conflict. August 8, 2007Special:Badtitle/NS100:FDA Advisors Under Review for the Potential of Financial Conflict
  38. FDA Panel Recommends Approval of New DESSpecial:Badtitle/NS100:FDA Panel Recommends Approval of New DES
  39. FDA Panel Review of Ticagrelor on July 28th, 2010FDA panel review of ticagrelor on July 28th, 2010
  40. FDA Requires Stronger Heart Failure Warning for Avandia and ActosSpecial:Badtitle/NS100:FDA Requires Stronger Heart Failure Warning for Avandia and Actos
  41. FDGFluorodeoxyglucose
  42. FDG-PETPositron emission tomography
  43. FDPFibrin degradation product
  44. FEESFlexible fiberoptic endoscopic examination of swallowing
  45. FEMINAAddition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
  46. FEMSEPTEstradiol
  47. FENIBFamilial encephalopathy with neuroserpin inclusion bodies
  48. FENaFractional sodium excretion
  49. FERRIC-HFEffect Of Intravenous Ferrous Sucrose On Exercise Capacity In Chronic Heart Failure
  50. FESFat embolism syndrome

View ( | ) (20 | 50 | 100 | 250 | 500)